Read the full article here. Canary Speech’s ongoing efforts to utilize voice analysis in diagnosing Alzheimer’s disease and mild cognitive […]
Read moreRead the full article here. Canary Speech’s ongoing efforts to utilize voice analysis in diagnosing Alzheimer’s disease and mild cognitive […]
Read moreIdentifying and addressing mild cognitive impairment (MCI) and other neurological conditions is difficult, subjective, and costly. In a partnership with […]
Read moreIn recent years, the fields of voice biomarkers and emotional analysis have garnered significant attention for their potential applications in […]
Read moreOne of the most robust voice biomarker studies ever conducted has been launched at Ulster University using Canary Speech’s patented […]
Read moreWe are delighted to announce Patty Kuppenbender as Chief Revenue Officer at Canary Speech. In her new role, Patty will […]
Read moreSchedule a demo with us to learn how Canary's patented vocal biomarker platform works. Explore assessments and screening to see how Canary analyzes and tracks the presence and severity of targeted illnesses.